Home › Funds › ELKHORN PARTNERS LIMITED PARTNERSHIP › GEHC
ELKHORN PARTNERS LIMITED PARTNERSHIP position in GEHC
GE HEALTHCARE TECHNOLOGIES I · Health Care
ELKHORN PARTNERS LIMITED PARTNERSHIP reported holding 1,600 shares of GEHC (GE HEALTHCARE TECHNOLOGIES I) in its Q3 2026 13F filing — a position valued at US$105K, representing 0.09% of its reported portfolio and ranking #29 among its reported holdings. ELKHORN PARTNERS LIMITED PARTNERSHIP has disclosed GEHC holdings in 5 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ELKHORN PARTNERS LIMITED PARTNERSHIP's GEHC position evolved
ELKHORN PARTNERS LIMITED PARTNERSHIP first disclosed a stake in GEHC in Q2 2024 at 400 shares (US$31K). The position peaked in Q3 2026 at 1,600 shares, worth US$105K. Across 5 filings, ELKHORN PARTNERS LIMITED PARTNERSHIP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,600 shares valued at US$105K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 400 | $31.00K | New |
| Q4 2024 | 600 | $47.00K | New |
| Q2 2025 | 300 | $22.22K | New |
| Q2 2026 | 1.60K | $102.42K | New |
| Q3 2026 | 1.60K | $104.59K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GEHC and 13F data
GEHC (GE HEALTHCARE TECHNOLOGIES I) is a Health Care company. 27 other funds we track also report a position in GEHC — the largest reported positions include Dodge & Cox (US$2.42B), DODGE & COX (US$2.42B), Harris Associates (Oakmark) (US$981.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GEHC
- Dodge & Cox 37.86M sh · $2.42B · Q2 2026
- DODGE & COX 37.86M sh · $2.42B · Q2 2026
- Harris Associates (Oakmark) 15.33M sh · $981.25M · Q2 2026
- HARRIS ASSOCIATES L P 15.33M sh · $981.25M · Q2 2026
- BARROW HANLEY MEWHINNEY & STRAUSS LLC 13.77M sh · $900.14M · Q3 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 12.25M sh · $784.15M · Q2 2026
- TRIAN FUND MANAGEMENT, L.P. 3.09M sh · $197.49M · Q2 2026
More on ELKHORN PARTNERS LIMITED PARTNERSHIP
FAQ
How long has ELKHORN PARTNERS LIMITED PARTNERSHIP held GEHC?
ELKHORN PARTNERS LIMITED PARTNERSHIP has disclosed GEHC holdings in 5 of the last 10 reported quarters, going back to Q2 2024.
What is ELKHORN PARTNERS LIMITED PARTNERSHIP's current position in GEHC?
As of Q3 2026, ELKHORN PARTNERS LIMITED PARTNERSHIP holds 1.60K shares of GEHC (GE HEALTHCARE TECHNOLOGIES I), valued at $104.59K, representing 0.09% of its reported portfolio and ranking #29.
Has ELKHORN PARTNERS LIMITED PARTNERSHIP been buying or selling GEHC?
In the latest 13F filing (Q3 2026), ELKHORN PARTNERS LIMITED PARTNERSHIP held unchanged its position in GEHC. The position peaked in Q3 2026 at 1.60K shares.
Which other funds hold GEHC?
Other major institutional holders of GEHC include Dodge & Cox, DODGE & COX, Harris Associates (Oakmark), among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.